chronic lymphocytic leukemia
Showing 26 - 50 of 600
Lymphoproliferative Disorders, Premalignant, Monoclonal B-Cell Lymphocytosis Trial (No intervention)
Not yet recruiting
- Lymphoproliferative Disorders
- +3 more
- No intervention
- (no location specified)
Jan 30, 2023
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Rochester (Biospecimen Collection, Bone Marrow Aspiration,
Recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Biospecimen Collection
- +7 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Feb 1, 2023
HIV, Organ Transplantation, Lymphoma, Non-Hodgkin Trial in Melbourne (Pfizer Bivalent COVID-19 Vaccine, Moderna Bivalent mRNA
Recruiting
- HIV
- +5 more
- Pfizer Bivalent COVID-19 Vaccine
- Moderna Bivalent mRNA vaccine
-
Melbourne, Victoria, AustraliaAlfred Health
Jan 31, 2023
Anemia, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in United States (drug, other, biological)
Active, not recruiting
- Anemia
- +2 more
- Cyclophosphamide
- +6 more
-
Birmingham, Alabama
- +795 more
Jan 28, 2023
Acute Lymphoblastic Leukemia, Adult B-Cell, Chronic Lymphocytic Leukemia, Multiple Myeloma Trial in United States (clonoSEQ
Recruiting
- Acute Lymphoblastic Leukemia, Adult B-Cell
- +3 more
- clonoSEQ Assay
-
Stanford, California
- +15 more
Jan 30, 2023
Non-Hodgkin's Lymphoma, Relapsed, Chronic Lymphoid Leukemia in Relapse, Non-Hodgkin's Lymphoma Refractory Trial in United States
Completed
- Non-Hodgkin's Lymphoma, Relapsed
- +8 more
- PBCAR20A
- +2 more
-
Duarte, California
- +4 more
Jan 4, 2023
B-cell Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Charleston (Cyclophosphamide injection, Fludarabine
Not yet recruiting
- B-cell Non Hodgkin Lymphoma
- Chronic Lymphocytic Leukemia
- Cyclophosphamide injection
- +2 more
-
Charleston, South CarolinaHollings Cancer Center at Medical University of South Carolina
Jan 18, 2023
Clinical, Laboratory and Epidemiologic Characterization of
Recruiting
- Waldenstrom Macroglobulinemia
- +4 more
-
Bethesda, Maryland
- +1 more
Jan 25, 2023
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Leukemia in Remission, Acute Lymphoblastic Leukemia
Active, not recruiting
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +36 more
- Cyclophosphamide
- +4 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Jan 23, 2023
Malignant Tumors Stated as Primary Lymphoid Haematopoietic, Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia Trial in
Active, not recruiting
- Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jan 20, 2023
Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Acute Lymphoblastic Leukemia Trial in Tampa (Fludarabine, Cyclophosphamide,
Recruiting
- Chronic Lymphocytic Leukemia
- +4 more
- Fludarabine
- +2 more
-
Tampa, FloridaMoffitt Cancer Center
Jan 12, 2023
Autoimmune Hemolytic Anemia, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial (Ibrutinib 420 mg)
Not yet recruiting
- Autoimmune Hemolytic Anemia
- +3 more
- Ibrutinib 420 mg
- (no location specified)
Jan 12, 2023
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in United States (Ublituximab, Umbralisib, Venetoclax)
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Ublituximab
- +2 more
-
Birmingham, Alabama
- +49 more
Jan 20, 2023
Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Australia, Poland (TG-1701, Umbralisib, Ublituximab)
Active, not recruiting
- Non Hodgkin Lymphoma
- Chronic Lymphocytic Leukemia
- TG-1701
- +2 more
-
East Melbourne, Victoria, Australia
- +7 more
Jan 20, 2023
Chronic Lymphocytic Leukemia Trial in Salt Lake City (Nicotinamide, Placebo)
Recruiting
- Chronic Lymphocytic Leukemia
- Nicotinamide
- Placebo
-
Salt Lake City, UtahHuntsman Cancer Institute at University of Utah
Jan 17, 2023
Colorectal Cancer, Hematologic Malignancy, Rectum Cancer Trial in Cleveland (Vactosertib, Fludarabine Phosphate,
Recruiting
- Colorectal Cancer
- +11 more
- Vactosertib
- +4 more
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
Jan 18, 2023
Chronic Lymphocytic Leukemia Trial in Russian Federation
Recruiting
- Chronic Lymphocytic Leukemia
-
Irkutsk, Russian Federation
- +5 more
Jan 17, 2023
Chronic Lymphocytic Leukemia Trial in Worldwide (Acalabrutinib, Venetoclax, Chemoimmunotherapy)
Recruiting
- Chronic Lymphocytic Leukemia
- Acalabrutinib
- +3 more
-
Fountain Valley, California
- +201 more
Jan 16, 2023
Aggressive Non-Hodgkin Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-Cell Lymphoma Trial in United States
Active, not recruiting
- Aggressive Non-Hodgkin Lymphoma
- +14 more
- Cholecalciferol
- Laboratory Biomarker Analysis
-
Scottsdale, Arizona
- +4 more
Jan 16, 2023
MEOI and HRQoL in CLL Patients Treated With BTKis
Recruiting
- Chronic Lymphocytic Leukemia
-
Fountain Valley, California
- +15 more
Jan 16, 2023
Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma Trial in United States (Zilovertamab vedotin)
Active, not recruiting
- Chronic Lymphocytic Leukemia
- +11 more
- Zilovertamab vedotin
-
Duarte, California
- +13 more
Jan 12, 2023
SARS-CoV-2 Vaccines in Chronic Lymphocytic Leukemia or Small
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Biospecimen Collection
- Electronic Health Record Review
-
Duarte, California
- +10 more
Jan 12, 2023
Adult Chronic Lymphocytic Leukemia Receiving Oral Venetoclax
Recruiting
- Chronic Lymphocytic Leukemia
-
London, London, City Of, United Kingdom
- +9 more
Jan 13, 2023
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Tampa (High Dose Methylprednisolone (HDMP), Ofatumumab,
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- High Dose Methylprednisolone (HDMP)
- +2 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Jan 12, 2023